Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection

European Journal of Medicinal Chemistry

Volumn 70, Issue , 2013, Pages 165-188

  Singh, Manjinder ^a   Kaur, Maninder ^a   Kukreja, Hitesh ^a   Chugh, Rajan ^a   Silakari, Om ^a   Singh, Dhandeep ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Acetylcholine; Acetylcholinesterase; Alzheimer's disease; Nerve gases

Indexed keywords

AP 2238; APIGENIN; BENZOPHENONE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CARVEDILOL; CHOLINESTERASE INHIBITOR; COUMARIN DERIVATIVE; DONEPEZIL; FANGQUINOLINE; GALANGIN; GALANTAMINE; HUPERZINE A; IMIDAZOLE; ISOQUINOLINE ALKALOID; LUTEOLIN; LYCORINE; MEMANTINE; METRIFONATE; OROXYLIN A; PHENOTHIAZINE; PHYSOSTIGMINE; PIPERIDINE; RIVASTIGMINE; SANGUINARINE; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; CASHEW NUT; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; COMPETITIVE INHIBITION; DEMENTIA; DRUG BINDING; ENDOPLASMIC RETICULUM; HUMAN; HYDROLYSIS; INTELLIGENCE; LIGAND BINDING; LIVER TOXICITY; MEMORY; MEMORY CONSOLIDATION; MICROTUBULE; NEUROCHEMISTRY; NEUROMUSCULAR BLOCKING; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; REVIEW; SITE DIRECTED MUTAGENESIS; SKILL; SOLID STATE FERMENTATION; STRUCTURE ACTIVITY RELATION; UPREGULATION;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALZHEIMER'S DISEASE; NERVE GASES;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; CHOLINESTERASE INHIBITORS; DRUG DESIGN; HUMANS; MOLECULAR STRUCTURE;

EID: 84885816253     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.09.050     Document Type: Review

References (203)

1. C. Snyder, and M.D. Lusdwig Laqueur I saw for the first time in front of both my eyes the ominous colored halos Arch. Ophthalmol. 72 1964 111 113
2. M. Eto Organophosphorus Pesticides: Organic and Biological Chemistry 1974 CRC Press Inc. Cleveland, Ohio 57 121
3. A.T. Tu Basic information on nerve gas and the use of sarin by Aum Shinrikyo J. Mass Spectrom. Soc. Jpn. 44 1996 293 320
4. T.C. Marrs, R.L. Maynard, and F.R. Sidell Organophosphates nerve agents Chemical Warfare Agents: Toxicology and Treatment 1996 John Wiley & Sons New York 83 100
5. J. Kassa Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents J. Toxicol. Clin. Toxicol. 40 2002 803 816 (Pubitemid 35428793)
6. H. Landsberg Prelude to the discovery of penicillin Isis 40 1949 225 227
7. F. Gaertner, and L. Kim Current applied recombinant DNA projects Trends Ecol. Evol. 3 1988 S4 S7
8. M.B. Graeber, S. Kosel, E. Grasbon-Frodl, H. Moller, and P. Mehraein Histopathology and APOE genotype of the first Alzheimer's disease patient Auguste D Neurogenetics 1 1998 223 228 (Pubitemid 128684245)
9. A.K. Ghosh, M. Brindisi, and J. Tang Developing β-secretase inhibitors for treatment of Alzheimer's disease J. Neurochem. 1 2012 71 83
10. M. Pettersson, A.F. Stepan, G.W. Kauffman, and D.S. Johnson Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012 Neurosci. Med. Chem. 23 2013 1 18
11. W.K. Summers, Administration of monoamine acridines in cholinergic neuronal deficit states, US 4816456, 1989.
12. M. Pievani, W. de Haan, T. Wu, W.W. Seeley, and G.B. Frisoni Functional network disruption in the degenerative dementias Lancet Neurol. 10 2011 829 843
13. R.J. Caselli, and B.F. Boeve The degenerative dementias C.G. Goetz, Textbook of Clinical Neurology third ed. 2007 Saunders Elsevier Philadelphia 699 702
14. M. Goedert, and M.G. Spillantini A century of Alzheimer's disease Science 314 2006 777 781 (Pubitemid 44706636)
15. L.M. Bolognesi, A. Cavalli, M.V.L. Bartolini, M. Rosini, V. Andrisano, M. Recanatini, and C. Melchiorre Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease J. Med. Chem. 50 2007 6446 6449 (Pubitemid 350309081)
16. M. Storandt Cognitive deficits in the early stages of Alzheimer's disease Assoc. Psychol. Sci. 17 2008 198 202
17. L.R. Squire Memory systems of the brain: a brief history and current perspective Neurobiol. Learn. Mem. 82 2004 171 177 (Pubitemid 39298714)
18. M.J. Berridge Calcium hypothesis of Alzheimer's disease Pflugers Arch. 459 2010 441 449
19. R.H. Wilkins, and I.A. Brody Alzheimer's disease Arch. Neurol. 21 1969 109 110
20. A. Alzheimer Over a eigenartigo disease of the cerebral cortex Allg. Z. Psychiat. 64 1907 146 148
21. F.H. Crick, L. Barnett, S. Brenner, and R.J. Watts-Tobin General nature of the genetic code for proteins Nature 192 1961 1227 1232
22. R.D. Terry, N.K. Gonatas, and M. Weiss Ultrastructural studies in Alzheimer's presenile dementia Am. J. Pathol. 44 1964 269 297
23. R.D. Terry The fine structure of neurofibrillary tangles in Alzheimer's disease J. Neuropathol. Exp. Neurol. 22 1963 629 642
24. H.M. Wiśniewski, H.K. Narang, and R.D. Terry Neurofibrillary tangles of paired helical filaments J. Neurol. Sci. 27 1976 173 181
25. R. Katzman The prevalence and malignancy of Alzheimer's disease Arch. Neurol. 33 1976 299 308
26. R. Katzman, and K. Bick The rediscovery of Alzheimer disease during the 1960s and 1970s P.J. Whitehouse, k. Maurer, M.A. Ballenger, Concepts of Alzheimer's Disease, Biological, Clinical, and Cultural Perspectives 2000 Johns Hopkins University Press Baltimore 104 114
27. J. Gehrmann, Y. Matsumoto, and G.W. Kreutzberg Microglia: intrinsic immuneffector cell of the brain Brain Res. Rev. 20 1995 269 287
28. A. Ott, R.P. Stolk, F. van Harskamp, H.A. Pols, A. Hofman, and M.M. Breteler Diabetes mellitus and the risk of dementia: the Rotterdam study Neurology 53 1999 1937 1942
29. M. Prince, M. Cullen, and A. Mann Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial Neurology 44 1994 97 104 (Pubitemid 24029437)
30. R. Katzman, and K. Bick The cholinergic story: hope for the patient and family Alzheimer Disease, the Changing View first ed. 2000 Academic Press London 182 (Chapter 5)
31. P.M. Arce, R.I.M. Franco, G.C.G. Munoz, C. Perez, B. Lopez, M. Villaroya, G.M. Lopez, and G.A. Garcia Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease J. Med. Chem. 22 2009 7249 7257
32. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120 1984 885 890 (Pubitemid 14104991)
33. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
34. D.J. Selkoe, and D. Schenk Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics Annu. Rev. Pharmacol. Toxicol. 43 2003 545 584 (Pubitemid 37372653)
35. L.M. Bekris, C. Yu, T.D. Bird, and D.W. Tsuang Genetics of Alzheimer disease J. Geriatr. Psychiatry Neurol. 23 2010 213 227
36. F. Liu, M.A. Ikram, A.C. Janssens, M. Schuur, I. de Koning, A. Isaacs, M. Struchalin, A.G. Uitterlinden, J.T. den Dunnen, K. Sleegers, K. Bettens, C. Van Broeckhoven, J. van Swieten, A. Hofman, B.A. Oostra, Y.S. Aulchenko, M.M. Breteler, and C.M. van Duijn A study of the SORL1 gene in Alzheimer's disease and cognitive function J. Alzheimer's Dis. 18 2009 51 64
37. B.J. Tabner, O.M. El-Agnaf, S. Turnbull, M.J. German, K.E. Paleologou, Y. Hayashi, L.J. Cooper, N.J. Fullwood, and D. Allsop Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia J. Biol. Chem. 280 2005 35789 35792 (Pubitemid 41633844)
38. K. Leuner, S. Hauptmann, R. Abdel-Kader, I. Scherping, U. Keil, J.B. Strosznajder, A. Eckert, and W.E. Muller Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease Antioxid. Redox Signal. 9 2007 1659 1675 (Pubitemid 47462969)
39. N. Crespo-Biel, C. Theunis, and F.V. Leuven Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease Int. J. Alzheimer's Dis. 2012 2012 1 13
40. M. Goedert, M.G. Spillantini, and R.A. Crowther Tau proteins and neurofibrillary degeneration Brain Pathol. 1 1991 279 286
41. K. Iqbal, A.C. Alonso, S. Chen, M.O. Chohan, E. El-Akkad, C.X. Gong, S. Khatoon, B. Li, F. Liu, A. Rahman, H. Tanimukai, and I. Grundke-Iqbal Tau pathology in Alzheimer disease and other tauopathies Biochim. Biophys. Acta 1739 2005 198 210 (Pubitemid 40018538)
42. W. Chun, and G.V. Johnson The role of tau phosphorylation and cleavage in neuronal cell death Front. Biosci. 12 2007 733 756 (Pubitemid 46860209)
43. L. Bojarski, J. Herms, and J. Kuznicki Calcium dysregulation in Alzheimer's disease Neurochem. Int. 52 2008 621 633
44. K.N. Green, and F.M. LaFerla Linking calcium to Aβ and Alzheimer's disease Neuron 59 2008 190 194
45. N. Pierrot, S.F. Santos, C. Feyt, M. Morel, J.P. Brion, and J.N. Octave Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation J. Biol. Chem. 281 2006 39907 39914 (Pubitemid 46041794)
46. H.W. Querfurth, and D.J. Selkoe Calcium ionophore increases amyloid beta peptide production by cultured cells Biochemistry 33 1994 4550 4561 (Pubitemid 24145103)
47. C. Edlund, M. Söderberg, and K. Kristensson Isoprenoids in aging and neuro degeneration Neurochem. Int. 25 1994 35 38
48. G. Johnson, and W.S. Moore The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design Curr. Pharm. Des. 12 2006 217 225
49. A. Shafferman, C. Kronman, A. Flashner, M. Leitner, H. Grosfed, A. Ordentlich, Y. Gozes, S. Cohen, N. Ariel, and D. Barak Mutagenesis of human acetyl cholinesterase. Identification of residue involved in the catalytic activity and in polypeptide folding J. Biol. Chem. 267 1992 17640 17648
50. A. Shafferman, D. Barak, D. Kaplan, A. Ordentlich, C. Kronman, and B. Velan Functional requirements for the optimal catalytic configuration of the AChE active center Chem. Biol. Interact. 157 2005 123 131 (Pubitemid 41757642)
51. L. Blichfeldt-Lauridsen, and B.D. Hansen Anesthesia and myasthenia gravis Acta Anaesthesiol. Scand. 56 2012 17 22
52. R.M. Lane, S.G. Potkin, and A. Enz Targetting acetylcholinesterase and butyrylcholinesterase in dementia Int. J. Neuropsychopharmacol. 9 2006 101 124
53. G. Zimmerman, and H. Soreq Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission Cell Tissue Res. 326 2006 655 669 (Pubitemid 44435832)
54. D.M. Quinn Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states Chem. Rev. 87 1987 955 979
55. J. Massoulié, and S. Bon The molecular forms of cholinesterase and acetylcholinesterase in vertebrates Annu. Rev. Neurosci. 5 1982 57 106
56. 2-terminal and active center sequences J. Biol. Chem. 260 1985 12185 12189 (Pubitemid 16228385)
57. N.K. Schaffer, H.O. Michel, and A.F. Bridges Amino acid sequence in the region of the reactive serine residue of eel acetylcholinesterase Biochemistry 12 1973 2946 2950
58. T.L. Rosenberry Acetylcholinesterase Adv. Enzymol. Relat. Areas Mol. Biol. 43 1975 103 218
59. M. Harel, I. Schalk, L. Ehret-Sabatier, F. Bouet, M. Goeldner, C. Hirth, P.H. Axelsen, I. Silman, and J.L. Sussman Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase Proc. Natl. Acad. Sci. 90 1993 9031 9035 (Pubitemid 23306445)
60. J. Massoulie, A. Anselmet, S. Bon, E. Krejci, C. Legay, N. Morel, and S. Simon Acetylcholinesterase: C-terminal domains, molecular forms and functional localization J. Physiol. (Paris) 92 1998 183 190 (Pubitemid 29050931)
61. T.L. Rosenberry, P. Barnett, and C. Mays Acetylcholinesterase Meth. Enzymol. 82 1982 325 339
62. M. Pohanka Cholinesterases, a target of pharmacology and toxicology Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 155 2011 219 230
63. H.A. Berman, J. Yguerabide, and P. Taylor Fluorescence energy transfer on acetylcholinesterase: spatial relationship between peripheral site and active center Biochemistry 19 1980 2226 2235
64. G. Mooser, and D.S. Sigman Ligand binding properties of acetylcholinesterase determined with fluorescent probes Biochemistry 13 1974 2299 2307
65. P. Taylor, and S. Lappi Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding Biochemistry 14 1975 1989 1997
66. H.A. Berman, and P. Taylor Fluorescent phosphonate label for serine hydrolases, pyrenebutyl methylphosphonofluoridate: reaction with acetylcholinesterase Biochemistry 17 1978 1704 1713 (Pubitemid 8329616)
67. H.A. Berman, W. Becktel, and P. Taylor Spectroscopic studies on acetylcholinestrase: influence of peripheral site occupation on active-centre conformation Biochemistry 20 1981 4803 4810
68. N.C. Inestrosa, M.C. Dinamarca, and A. Alvarez Amyloid-cholinesterase interactions. Implications for Alzheimer's disease FEBS J. 275 2008 625 632 (Pubitemid 351160969)
69. H. Haviv, D.M. Wong, I. Silman, and J.L. Sussman Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors Curr. Top. Med. Chem. 7 2007 375 387 (Pubitemid 46358650)
70. J. Eichler, A. Anselment, J.L. Sussman, J. Massoulie, and I. Silman Differential effects of peripheral site ligands on Torpedo and chicken acetylcholinesterase Mol. Pharmacol. 45 1994 335 340
71. A. Castro, and A. Martinez Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment Alzheimer's disease Mini-Rev. Med. Chem. 1 2001 267 272
72. A. Alvarez, C. Opazo, R. Alarcon, J. Garrido, and N.C. Inestrosa Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils J. Mol. Biol. 272 1997 348 361 (Pubitemid 27410049)
73. A. Alvarez, R. Alarcon, C. Opazo, E.O. Campos, F.J. Munoz, F.H. Calderon, F. Dajas, M.K. Gentry, B.P. Doctor, F.G. De Mello, and N.C. Inestrosa Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils J. Neurosci. 18 1998 3213 3223 (Pubitemid 28186014)
74. G.V. De Ferrari, M.A. Canales, I. Shin, L.M. Weiner, I. Silman, and N.C. Inestrosa A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation Biochemistry 40 2001 10447 10457 (Pubitemid 32816655)
75. N.C. Inestrosa, A. Alvarez, C.A. Perez, R.D. Moreno, M. Vicente, and C. Linker Acetyl cholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme Neuron 16 1996 881 891 (Pubitemid 26124065)
76. S.N. Abramson, Z. Radic, D. Manker, D.J. Faulkner, and P. Taylor Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action Mol. Pharmacol. 36 1989 349 354 (Pubitemid 19245378)
77. W. Carmichael The toxins of cyanobacteria Sci. Am. 270 1994 78 86
78. S. Matsunaga, R.E. Moore, W.P. Niemczura, and W.W. Carmichael Anatoxin-a(s), a potent anticholinesterase from Anabaena flos-aquae J. Am. Chem. Soc. 111 1989 8021 8023
79. M. Harel, G.J. Kleywegt, R.B.G. Ravelli, I. Silman, and J.L. Sussman Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target Structure 3 1995 1355 1366 (Pubitemid 3012267)
80. B. Goozner, L.I. Lutwick, and E. Bourke Chemical terrorism: a primer for 2002 J. Assoc. Acad. Minor. Phys. 13 2002 14 18
81. Y. Solberg, and M. Belkin The role of excitotoxicity in organophosphorous nerve agents central poisoning Trends Pharmacol. Sci. 18 1997 183 185 (Pubitemid 27283644)
82. J. Bajgar Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment Adv. Clin. Chem. 38 2004 151 216
83. T. Namba, C.T. Nolte, J. Jackrel, and D. Grob Poisoning due to organophosphate insecticides Am. J. Med. 50 1971 475 492
84. F.R. Sidell, and J. Borak Chemical warfare agents: II. Nerve agents Ann. Emerg. Med. 21 1992 865 871
85. C.P. Holstege, M. Kirk, and F.R. Sidell Chemical warfare: nerve agent poisoning Crit. Care Clin. 4 1997 923 942 (Pubitemid 27432898)
86. G.B. Koelle, R.L. Volle, B. Holmstedt, A.G. Karczmar, and R.D. O'brien Anticholinesterase agents Science 141 1963 63 65
87. W.P. Bozeman, D. Dilberio, and J.L. Schauben Biologic and chemical weapons of mass destruction Emerg. Med. Clin. North Am. 20 2002 975 993 (Pubitemid 35403485)
88. E.E. Rosenbaum, R.J. Hersechler, and S.W. Jacob An antidote to parathion poisoning: pralidoxime chloride (Protopam chloride) J. Am. Med. Assoc. 192 1965 314 315
89. R.F. Clark Insecticides: organic phosphorus compounds and carbamates L.R. Goldfrank, N.E. Flomenbaum, N.A. Lewin, M.A. Howland, R.S. Hoffman, L.S. Nelson, Goldfrank's Toxicologic Emergencie seventh ed. 2002 McGraw-Hill New York 1346 1360
90. R.T. Delfino, T.S. Ribeiro, and J.D. Figueroa-Villar Organophosphorus compounds as chemical warfare agents: a review J. Braz. Chem. Soc. 20 2009 407 428
91. J. Paxman, and R.A. Harris Higher Form of Killing: the Secret Story of Chemical and Biological Warfare 1982 Hill and Wang New York 138 139
92. NE Museum, R. Kuhn, Biography, http://www.nobel.se/chemistry/laureates/ 1938/kuhn-bio.html.
93. J.K. Smart History of chemical and biological warfare: an American perspective F.R. Sidell, E.T. Takafuji, D.R. Franz, Medical Aspects of Chemical and Biological Warfare Textbook of Military Medicine, Part I: Warfare Weaponry, and the Casualty 1997 Office of the Surgeon General Washington, DC 9 86
94. H. Daly, J.T. Doyen, and A.H. Purcell Introduction to Insect Biology and Diversity (Chapter 13) second ed. 1998 Oxford University Press New York 279 300
95. T.R. Fukuto Mechanism of action of organophosphorus and carbamate insecticides Environ. Health Perspect. 87 1990 245 254 (Pubitemid 20316924)
96. M.B. Abou-Donia Organophosphorus ester-induced delayed neurotoxicity Annu. Rev. Pharmacol. Toxicol. 21 1981 511 548
97. S.Y. Wu, and J.E. Casida Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors Toxicol. Appl. Pharmacol. 139 1996 195 202 (Pubitemid 26247077)
98. C.C. Yu, R.L. Metcalf, and G.M. Booth Inhibition of acetylcholinesterase from mammals and insects by carbofuran and its related compounds and their toxicities toward these animals J. Agric. Food Chem. 20 1972 923 926
99. F.R. Sidell Clinical effects of organophosphorus cholinesterase inhibitors J. Appl. Toxicol. 14 1994 111 113 (Pubitemid 24124987)
100. K. Hayden, M. Norton, D. Darcey, T. Ostbye, P. Zandi, J. Breitner, and K. Welsh-Bohmer Occupational exposure to pesticides increases the risk of incident AD: the Cache County study Neurology 19 2010 1524 1530
101. S. Barnes The influence of certain biological factors on the resistance of bed-bugs (Cimex lectularius, L.) to DDT Bull. Entomol. Res. 36 1946 419 422
102. S.C. Arya, and N. Agarwal A risk for returned travellers: the "post-antibiotic era" Med. J. Aust. 194 2011 55 56
103. F.J. Grundbacher Behring's discovery of diphtheria and tetanus antitoxins Immunol. Today 13 1992 188 190
104. A.M. Bain Historical note on poliomyelitis in Uganda East Afr. Med. J. 43 1966 62 64
105. J. Patrick, and J. Lindstrom Autoimmune response to acetylcholine receptor Science 180 1973 871 872
106. J.C. Keesey Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology Neurology 51 1998 1433 1439
107. H.C. Hartzell, S.W. Kuffler, and D. Yoshikami Post-synaptic potentiation: interaction between quanta of acetylcholine at the skeletal neuromuscular synapse J. Physiol. 25 1975 1427 1463
108. W.K. Summers, L.V. Majovski, G.M. Marsh, K. Tachiki, and A. Kling Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type N. Engl. J. Med. 315 1986 1241 1245 (Pubitemid 17049681)
109. B. Reisberg, R. Doody, A. Stoffler, F. Schmitt, S. Ferris, H.J. Mobius Memantine Study Group Memantine in moderate-to-severe Alzheimer's disease N. Engl. J. Med. 348 2003 1333 1341 (Pubitemid 36384100)
110. T.A. Pham, H. Che, P.T. Phan, J.W. Lee, S.S. Kim, and H. Park Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production Bioorg. Med. Chem. Lett. 22 2012 2534 2535
111. E.J. Barreiro, C.A. Camara, H. Verli, L. Brazil-Mas, N.G. Castro, W.M. Cintra, Y. Aracava, C.R. Rodrigues, and C.A.M. Fraga Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors J. Med. Chem. 46 2003 1144 1152 (Pubitemid 36428220)
112. J.L. Marco, C. De los Rios, M.C. Carreiras, J.E. Banos, A. Badia, and N.M. Vivas Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro(and thieno)[2,3-b]- quinolines, and 4-amino-5,6,7,8,9-pentahydro-2,3-diphenylcyclohepta[e]furo(and thieno)-[2,3-b]pyridines Arch. Pharm. 7 2002 347 353
113. J.L. Marco, C. De los Rios, M.C. Carreiras, J.E. Banos, A. Badia, and N.M. Vivas Synthesis and acetylcholinesterase/butylcholinesterase inhibition activity of tacrine like analogs Bioorg. Med. Chem. 9 2001 727 732 (Pubitemid 32208592)
114. 2+ channels and nicotinic receptors Bioorg. Med. Chem. 12 2004 2199 2218 (Pubitemid 38471708)
115. G. Petroianu, K. Arafat, C. Sasse, and H. Stark Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents Pharmazie 61 2003 179 182
116. S. Morisset, E. Traiffort, and J.C. Schwartz Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity Eur. J. Pharmacol. 315 1996 R1 R2
117. M. Rosini, V. Andrisano, M. Bartolini, M.L. Bolognesi, P. Helia, A. Minarini, A. Tarozzi, and C. Melchiorre Rational approach to discover multipotent anti-Alzheimer drugs J. Med. Chem. 48 2005 360 363 (Pubitemid 40139781)
118. A. Cappelli, A. Gallelli, M. Manini, M. Anzini, L. Mennuni, F. Makovec, M.C. Menziani, S. Alcaro, F. Ortuso, and S. Homer Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties J. Med. Chem. 48 2005 3564 3575 (Pubitemid 40667524)
119. Y. Pang, P. Quiram, T. Jelacic, F. Hong, and S. Brimijon Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase J. Biol. Chem. 271 1996 23646 23649
120. M.I. Rodriguez-Franco, M.I. Fernandez-Bachiller, C. Perez, B. Hernandez-Ledesma, and B. Bartolome Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties J. Med. Chem. 49 2006 459 462 (Pubitemid 43157478)
121. D. Alonso, I. Dorronsoro, L. Rubio, and P. Munoz Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE Bioorg. Med. Chem. 13 2005 6588 6597 (Pubitemid 41571203)
122. P. Camps, X. Formosa, C. Galdeano, T. Gomez, D. Munoz-Torrero, M. Scarpellini, E. Viayna, A. Badia, M.V. Clos, A. Camins, M. Pallas, M. Bartolini, F. Mancini, V. Andrisano, J. Estelrich, M. Lizondo, A. Bidon-Chanal, and F.J. Luque Novel donepezil-based inhibitors of acetyl-and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation J. Med. Chem. 51 2008 3588 3598 (Pubitemid 351875014)
123. A. Villalobos, J.F. Blake, C.K. Biggers, T.W. Butler, D.S. Chapin, Y.L. Chen, J.L. Ives, S.B. Jones, D.R. Liston, and A.A. Nagel Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase J. Med. Chem. 37 1994 2721 2734 (Pubitemid 24273464)
124. A. Martinez, E. Fernandez, A. Castro, S. Conde, M.I. Rodriguez-Franco, J. Banos, and A. Badia N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors Eur. J. Med. Chem. 35 2000 913 922
125. A. Andreani, A. Cavalli, M. Granaiola, M. Guardigli, A. Leoni, A. Locatelli, R. Morigi, M. Rambaldi, M. Recanatini, and A. Roda Synthesis and screening for antiacetylcholinesterase activity of (1-benzyl-4-oxopiperidin-3- ylidene)methylindoles and pyrroles related to donepezil J. Med. Chem. 44 2001 4011 4014 (Pubitemid 33051491)
126. Y. Ishihara, K. Hirai, M. Miyamoto, and G. Goto Central cholinergic agents: synthesis and evaluation of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4, 5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanones and their analogs as central selective acetylcholinesterase inhibitors J. Med. Chem. 37 1994 2292 2299 (Pubitemid 24262317)
127. F. Belluti, L. Piazzi, A. Bisi, S. Gobbi, M. Bartolini, A. Cavalli, P. Valenti, and A. Rampa Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors Eur. J. Med. Chem. 44 2009 1341 1348
128. M.L. Bolonesi, M. Bartolini, A. Cavalli, V. Andrisano, M. Rosini, A. Minarini, and C. Melchiorre Design, synthesis and biological evaluation of conformationally restricted rivastigmine analogues J. Med. Chem. 47 2004 5945 5952 (Pubitemid 39507336)
129. N.F. Proskurnina, and A.P. Yakoleva Oral solution containing galanthamine and a sweetening agent J. Gen. Chem. 22 1957 1899 1902
130. G.M. Bores, and R.W. Kosley Galanthamine derivatives for the treatment of Alzheimer's disease Drugs Future 21 1996 621 635 (Pubitemid 26248069)
131. S. Lilienfeld Galantamine: a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease CNS Drug Rev. 8 2002 159 176 (Pubitemid 34874383)
132. M.D. Santos, M. Alkondon, E.F. Pereira, Y. Aracava, H.M. Eisenberg, A. Maelicke, and E.X. Albuquerque The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol. Pharmacol. 61 2002 1222 1234 (Pubitemid 34441788)
133. D. Herlem, M.T. Martin, C. Thal, and C. Guillou Synthesis and structure activity relationships of open d-ring galanthamine analogues Bioorg. Med. Chem. Lett. 13 2003 2389 2391 (Pubitemid 36724989)
134. P. Jia, R. Sheng, J. Zhang, L. Fang, Q. He, B. Yang, and Y. Hu Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors Eur. J. Med. Chem. 44 2009 772 784
135. D.J. Triggle, J.M. Mitchell, and R. Filler The pharmacology of physostigmine CNS Drug Rev. 4 1998 87 136 (Pubitemid 29090858)
136. Z.J. Zhan, H.L. Bian, W.J. Wang, and G.W. Shan Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities Bioorg. Med. Chem. Lett. 20 2010 1532 1534
137. S. Iijima, N.H. Greig, P. Garofalo, E.L. Spangler, B. Heller, A. Brossi, and D.K. Ingram Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze Psychopharmacology (Berlin, Germany) 112 1993 415 420 (Pubitemid 23324161)
138. C. Linden, and A. Alm Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes Arch. Ophthalmol. 115 1997 857 861 (Pubitemid 27299158)
139. C. Bartolucci, M. Siotto, E. Ghidini, G. Amari, P.T. Bolzoni, M. Racchi, G. Villetti, M. Delcanale, and D. Lamba Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-Alzheimer drug ganstigmine (CHF-2819) J. Med. Chem. 49 2006 5051 5058 (Pubitemid 44260202)
140. Q.S. Yu, H.W. Holloway, J.L. Flippen-Anderson, B. Hoffman, A. Brossi, and N.H. Grieg Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl and butyrylcholinesterase inhibitory action J. Med. Chem. 44 2001 4062 4071 (Pubitemid 33095315)
141. G. Orhan, I. Orhan, N. Oztekin-Subutay, F. Ak, and B. Sener Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease Recent Pat. CNS Drug Discovery 4 2009 43 51
142. Z.J. Zhan, H.L. Bian, J.W. Wang, and W.G. Shan Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities Bioorg. Med. Chem. Lett. 20 2011 1532 1534
143. W. Luo, Q.S. Yu, M. Zhan, D. Parrish, J.R. Deschamps, S.S. Kulkarni, H.W. Holloway, G.M. Alley, D.K. Lahiri, A. Brossi, and N.H. Greig Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine J. Med. Chem. 48 2005 986 994 (Pubitemid 40270444)
144. C. Viegas Jr., V.S. Bolzani, L.S. Pimentel, N.G. Castro, R.F. Cabral, R.S. Costa, C. Floyd, M.S. Rocha, M.C. Young, E.J. Barreiro, and C.A. Fraga New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids Bioorg. Med. Chem. 13 2005 4184 4190 (Pubitemid 40779387)
145. V.S. Bolzani, A.A.L. Gunatilaka, and D.G.I. Kingston Bioactive and other piperidine alkaloids from Cassia leptophylla Tetrahedron 51 1995 5929 5934
146. C. Viegas Jr., V.S. Bolzani, E.J. Barreiro, M.C. Young, M. Furlan, D. Tomazela, and M.N. Eberlin Further bioactive piperidine alkaloids from the flowers and green fruits of Cassia spectabilis J. Nat. Prod. 67 2004 908 910 (Pubitemid 38702758)
147. M.S. Alexandre-Moreira, C. Viegas Jr., A.L.P. Miranda, V.S. Bolzani, and E.J. Barreiro Antinociceptive profile of (-)-spectaline: a piperidine alkaloid from Cassia leptophylla Planta Med. 69 2003 795 799 (Pubitemid 37346564)
148. H. Jiang, X. Luo, and D. Bai Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease Curr. Med. Chem. 10 2003 2231 2252 (Pubitemid 37236384)
149. A. Badia, J.E. Banos, P. Camps, J. Contreras, D.M. Gorbig, D.M. Diego Munoz-Torrero, M. Simon, and N.M. Vivas Synthesis and evaluation of tacrine-huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease Bioorg. Med. Chem. 6 1998 427 440 (Pubitemid 28179584)
150. M. Mar Alcala, N.M. Vivas, S. Hospital, P. Camps, T.D. Munoz, and A. Badia Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids Neuropharmacology 44 2003 749 755 (Pubitemid 36385139)
151. P. Camps, X. Formosa, D. Munoz-Torrero, J. Petrignet, A. Badia, and V. Clos Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors J. Med. Chem. 48 2005 1701 1704 (Pubitemid 40396300)
152. M.T. Andrade, J.A. Lima, A.C. Pinto, C.M. Rezende, M.P. Carvalho, and R.A. Epifanio Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme Bioorg. Med. Chem. 13 2005 4092 4095 (Pubitemid 40725042)
153. S.S. Lee, U. Venkatesham, C.P. Rao, S.H. Lam, and J.H. Lin Preparation of secolycorines against acetylcholinesterase Bioorg. Med. Chem. 15 2007 1034 1043 (Pubitemid 44880704)
154. S. Markmee, S. Ruchirawat, V. Prachyawarakorn, K. Ingkaninan, and N. Khorana Isoquinoline derivatives as potential acetylcholinesterase inhibitors Bioorg. Med. Chem. Lett. 16 2006 2170 2172 (Pubitemid 43351072)
155. N. Khorana, S. Markmee, K. Ingkaninan, S. Ruchirawat, R. Kitbunnadaj, and M.R. Pullagurla Evaluation of a new lead for acetylcholinesterase inhibition Med. Chem. Res. 18 2009 231 241
156. T. Ogino, T. Yamaguchi, T. Sato, H. Sasaki, K. Sugama, M. Okada, and M. Maruno Studies on inhibitory activity against acetylcholinesterase of new bisbenzylisoquinoline alkaloid and its related compounds Heterocycles 45 1997 2253 2560
157. D.A. Bianchi, G.S. Hirschmann, C. Theoduloz, A.B.J. Bracca, and T.S. Kaufman Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors Bioorg. Med. Chem. Lett. 15 2005 2711 2715 (Pubitemid 40740203)
158. F. Belluti, A. Rampa, L. Piazzi, A. Bisi, S. Gobbi, M. Bartolili, V. Andrisano, A. Cavalli, M. Recanatini, and P. Valenti Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation J. Med. Chem. 48 2005 4444 4456 (Pubitemid 40884946)
159. L. Piazzi, F. Belluti, A. Bisi, S. Gobbi, S. Rizzo, M. Bartolini, V. Andrisano, and M. Recanatini Acetylcholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones Bioorg. Med. Chem. 15 2007 575 583
160. S.N. Kumar, P.K. Mukherjee, S. Bhadra, B.P. Saha, and B.C. Pal Acetyl cholinesterase inhibitory potential of a carbazole alkaloid, mahanimbine, from Murraya koenigii Phytother. Res. 24 2010 629 631
161. R.D. Howlett, R.A. George, E.D. Owen, V.R. Ward, and E.R. Markwell Common structural features determine the effectiveness of carvedilol, daunomycin and
162. L. Huang, A. Shi, F. He, and X. Li Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors Bioorg. Med. Chem. 18 2010 1244 1251
163. M. Rosini, E. Simoni, M. Bartolini, A. Cavalli, L. Ceccarini, N. Pascu, D.W. McClymont, A. Tarozzi, M.L. Bolognesi, A. Minarini, V. Tumiatti, V. Andrisano, I.R. Mellor, and C. Melchiorre Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush J. Med. Chem. 51 2008 4381 4384
164. W.G. Kim, K.M. Cho, C.K. Lee, and I.D. Yoo Terrelactone-A, a novel mero terpenoid with anti-acetyl cholinesterase activity from Aspergillus terreus Tetrahedron Lett. 43 2002 3197 3198
165. I.D. Yoo, K.M. Cho, C.K. Lee, and W.G. Kim Isoterreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity produced by Aspergillus terreus Bioorg. Med. Chem. Lett. 15 2005 353 356
166. J. Rouleau, B.I. Iorga, and C. Guillou New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β-aggregation Eur. J. Med. Chem. 46 2011 2193 2205
167. A. Khalid, Zaheer-ul-Haq, S. Anjum, M.R. Khan, Atta-ur-Rahman, and M.I. Choudhary Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases Bioorg. Med. Chem. 12 2004 1995 2003 (Pubitemid 38471693)
168. Zaheer-ul-Haq, B. Wellenzohn, K.R. Liedl, and B.M. Rode Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna J. Med. Chem. 46 2003 5087 5090 (Pubitemid 37352046)
169. J. Correa-Basurto, I.V. Alcantara, L. Michel, J. Espinoza-Fonseca, and G. Trujillo-Ferrara p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors Eur. J. Med. Chem. 40 2005 732 735 (Pubitemid 40797568)
170. J. Trujillo-Ferrara, L.M. Cano, and M. Espinoza-Fonseca Synthesis, anticholinesterase activity and structure-activity relationships of m-aminobenzoic acid derivatives Bioorg. Med. Chem. Lett. 13 2003 1825 1827 (Pubitemid 36561174)
171. C.T. Sadashiva, J.N. Narendra Sharath Chandra, K.C. Ponnappa, T. Veera-basappa Gowda, and K.S. Rangappa Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease Bioorg. Med. Chem. Lett. 16 2006 3932 3936 (Pubitemid 44425197)
172. J. Trujillo-Ferrara, I. Vazquez, J. Espinosa, R. Santillan, N. Farfan, and H. Hopfl Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase Eur. J. Pharm. Sci. 18 2003 313 322 (Pubitemid 36407691)
173. V. Alptüzün, P. Kapková, K. Baumann, E. Erciyas, and U. Holzgrabe Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors J. Pharm. Pharmacol. 55 2003 1397 1404 (Pubitemid 37321383)
174. P. Kapkova, V. Alptüzün, P. Frey, E. Erciyas, and U. Holzgrabe Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Aβ-fibril formation inhibition capacity Bioorg. Med. Chem. 14 2006 472 478 (Pubitemid 41767607)
175. P. Kapkova, N. Stiefl, U. Sürig, B. Engels, K. Baumann, and U. Holzgrabe Synthesis, biological activity and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type Arch. Pharm. (Weinheim) 336 2003 523 540 (Pubitemid 38005047)
176. M. Pietsch, and M. Gütschow Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition J. Med. Chem. 48 2005 8270 8288 (Pubitemid 43033318)
177. S. Darvesh, R.S. McDonald, A. Penwell, S. Conrad, K.V. Darvesh, D. Mataija, G. Gomez, A. Caines, R. Walsh, and E. Martin Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives Bioorg. Med. Chem. 13 2005 211 222 (Pubitemid 39575706)
178. M. Decker Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterase with dirigible selectivity toward butyrylcholinesterase J. Med. Chem. 49 2006 5411 5413 (Pubitemid 44373174)
179. M. Decker, F. Krauth, and J. Lehmann Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase Bioorg. Med. Chem. 14 2006 1966 1977 (Pubitemid 43199528)
180. A. Paz, Q. Xie, H.M. Greenblatt, W. Fu, Y. Tang, Z. Qiu, and J.L. Sussman The crystal structure of a complex of acetylcholinesterase with bis-(-)-nor-meptazinol derivative reveals disruption of the catalytic triad J. Med. Chem. 52 2009 2543 2549
181. H.R. Girisha, N.S. Chandra, S. Boppana, M. Malviya, C.T. Sadashiva, and S.R. Kanchugarakoppal Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase Eur. J. Med. Chem. 44 2009 4057 4062
182. G. Lin, C.Y. Lai, and W.C. Liao Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates Bioorg. Med. Chem. 7 1999 2683 2689 (Pubitemid 30105840)
183. G. Lin, H.C. Tseng, A.C. Chio, T.M. Tseng, and B.Y. Tsai A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates Bioorg. Med. Chem. Lett. 15 2005 951 955 (Pubitemid 40458629)
184. C. Mustazza, A. Borioni, M.R. Del Giudice, F. Gatta, R. Ferreti, A. Meneguz, M.T. Volpe, and P. Lorenzini Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease Eur. J. Med. Chem. 37 2002 91 109 (Pubitemid 34164676)
185. R. Sheng, X. Lin, J. Li, Y. Jiang, Z. Shang, and Y. Hu Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors Bioorg. Med. Chem. Lett. 15 2005 3834 3837 (Pubitemid 41095478)
186. H.A. Jung, Y.J. Jung, and S.K. Hyun Selective cholinesterase inhibitory activities of a new monoterpene diglycoside and other constituents from Nelumbo nucifera stamens Biol. Pharm. Bull. 33 2010 267 272
187. C. Seidl, B.L. Correia, A.E.M. Stinghen, and C.A.M. Santos Acetylcholinesterase inhibitory activity of uleine from Himatanthus lancifolius Z. Naturforsch. C 65 2010 440 444
188. A.J. Guo, H.Q. Xie, R.C. Choi, K.Y. Zheng, C.W. Bi, S.L. Xu, T.T. Dong, and K.W. Tsim Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro Chem. Biol. Interact. 187 2010 246 248
189. A.A.N. De Paula, J.B.L. Martins, and M.L. Dos Santos New potential AChE inhibitor candidates Eur. J. Med. Chem. 44 2009 3754 3759
190. J.M. López-Arrieta, and L. Schneider Metrifonate for Alzheimer's disease Cochrane Database Syst. Rev. 2 2006 1 88
191. P. Anand, B. Singh, and N. Singh A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease Bioorg. Med. Chem. 20 2012 1175 1180
192. H. Tang, Y.B. Wei, C. Zhang, F.X. Ning, W. Qiao, S.L. Huang, L. Ma, Z.S. Huang, and L.Q. Gu Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase Eur. J. Med. Chem. 44 2009 2523 2532
193. E.V.L. Da-Cunha, M.L. Cornelio, J.M. Barbosa-Filho, R. Braz-Filho, and A.I. Gray Eletefine, a stephaoxocane alkaloid from Cissampelos glaberrima J. Nat. Prod. 61 1998 1140 1142 (Pubitemid 28464746)
194. J.Z. Deng, and S.X. Zhao 2-N-Methylexcentricine, a new alkaloid from roots of Stephania excentrica J. Nat. Prod. 60 1997 294 295
195. N. Kashiwaba, S. Morooka, M. Kimura, and M. Ono Stephaoxocanine, a novel dihydroisoquinoline alkaloid from Stephania cepharantha J. Nat. Prod. 59 1996 803 805 (Pubitemid 26299175)
196. T.S. Kaufman, and A.B.J. Bracca Synthetic approaches to carnigine, a simple tetrahydroisoquinoline alkaloid Tetrahedron 60 2004 10575 10610 (Pubitemid 39377712)
197. S. Lopez, J. Bastida, F. Viladomat, and C. Codina Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts Life Sci. 71 2002 2521 2529 (Pubitemid 35247960)
198. J. Ulrichova, D. Walterova, V. Preininger, and V. Simanek Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids Planta Med. 48 1983 174 177 (Pubitemid 14234597)
199. H. Tang, L. Zhao, H. Zhao, S. Huang, S. Zhong, J. Qin, Z. Chen, Z. Huang, and H. Liang Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced b-amyloid aggregation inhibitors Eur. J. Med. Chem. 46 2011 4970 4979
200. M.I. Fernández-Bachiller, C. Pérez, L. Monjas, J. Rademann, and M.I. Rodríguez-Franco New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties J. Med. Chem. 55 2012 1303 1317
201. J. Korabecny, K. Musilek, and O. Holas Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease Bioorg. Med. Chem. Lett. 20 2010 6093 6095
202. O. Weinreb, T. Amit, O. Bar-Am, and M.B.H. Youdim A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor Int. Rev. Neurobiol. 100 2011 191 215
203. S. Rizzo, M. Bartolini, L. Ceccarini, L. Piazzi, S. Gobbi, A. Cavalli, M. Recanatini, V. Andrisano, and A. Rampa Targeting Alzheimer's disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238 Bioorg. Med. Chem. 18 2010 1749 1760